Moberg Pharma AB (publ) (STO:MOB)

Sweden flag Sweden · Delayed Price · Currency is SEK
9.48
+0.11 (1.12%)
Feb 10, 2026, 5:29 PM CET
Market Cap440.63M -5.2%
Revenue (ttm)12.50M +42.3%
Net Income-257.79M
EPS-5.51
Shares Out47.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41,781
Average Volume62,407
Open9.18
Previous Close9.38
Day's Range9.18 - 9.66
52-Week Range6.52 - 12.10
Beta1.15
RSI49.34
Earnings DateFeb 17, 2026

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol MOB
Full Company Profile

Financial Performance

Financial Statements